FDA Inspection
NerPharMa S.r.l.NerPharMa S.r.l. – FDA Inspection, Jun 1, 2017
Record Details
This FDA Inspection record concerns NerPharMa S.r.l., with an inspection on June 1, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 571aaaf5-a629-4505-80ec-c2bebfdbc4e1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1017090
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of NerPharMa S.r.l.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2025 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| September 13, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2024 | Not classified | Office of Inspections and Investigations | |
| February 20, 2023 | Not classified | Office of Inspections and Investigations | |
| January 17, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NerPharMa S.r.l.
- FDA Inspection 1273996 - 2025-06-27
- FDA Inspection 1271174 - 2024-09-13
- FDA Inspection 1243307 - 2024-06-19
- FDA Inspection 1199864 - 2023-02-20
- FDA Inspection 1142104 - 2020-01-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.